Gracure Pharmaceuticals Ltd.
Gracure Pharmaceuticals Ltd., a prominent player in the Indian pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1985, the company has established itself as a key provider of high-quality generic and specialty pharmaceuticals, focusing on areas such as oncology, cardiology, and anti-infectives. Gracure's commitment to innovation is evident in its diverse portfolio, which includes unique formulations and a range of active pharmaceutical ingredients (APIs). The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. With a reputation for quality and reliability, Gracure Pharmaceuticals continues to make strides in the healthcare sector, contributing to improved patient outcomes both domestically and internationally.
DitchCarbon Score
How does Gracure Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gracure Pharmaceuticals Ltd.'s score of 9 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gracure Pharmaceuticals Ltd.'s reported carbon emissions
Gracure Pharmaceuticals Ltd., headquartered in India, currently does not have available carbon emissions data, as indicated by the absence of specific figures for emissions in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company, suggesting a lack of formal commitments to address carbon emissions at this time. As the pharmaceutical industry increasingly focuses on sustainability, Gracure Pharmaceuticals may need to consider establishing measurable climate commitments and reduction initiatives to align with industry standards and expectations. Without specific emissions data or targets, it is challenging to assess their current environmental impact or future climate strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gracure Pharmaceuticals Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
